IGF-1 LR3is a synthetic analog ofInsulin-Like Growth Factor-1 (IGF-1)studied in laboratory environments investigating cellular growth signaling, metabolic regulation, and peptide-mediated biological pathways.
IGF-1 LR3 is a modified form of the naturally occurring IGF-1 peptide, designed with an extended amino acid sequence that increases its stability in research models. Each vial fromPEPTIDE MEDICSis supplied ashigh-purity lyophilized peptideand available in0.1mg and 1mg research vialsfor controlled scientific study.
All compounds distributed byFubonzoare intendedstrictly for laboratory research purposes only.